Rating for Stryker stock got an upgrade from 70 to 74. The upgraded 74 RS Rating shows that Stryker topped 74% of stocks for ...

Stryker announces agreement to acquire Inari Medical for $4.9 billion, resulting in a 21% jump in Inari's shares.

Stryker (NYSE:SYK – Get Free Report) was upgraded by research analysts at StockNews.com from a “hold” rating to a “buy” ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We came across a bullish thesis on Stryker Corporation (SYK) on Business Model Mastery’s Substack by The Antifragile Investor ...

Stryker SYK has outperformed the market over the past 20 years by 2.09% on an annualized basis producing an average annual ...

Stryker's acquisition of Inari for $4.9B enhances its neurovascular portfolio and boosts revenue growth by 50bp, with minimal ...

By diversifying its offerings and tapping into a robust market, Stryker can strengthen its competitive edge and drive long-term profitability, which is likely to positively influence investor ...

Stryker (SYK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Caitlin Cronin from ...

Tuesday, Stryker Corporation (NYSE:SYK) received a reaffirmation of its Buy rating and $435.00 price target from TD Cowen, as the company plans to acquire NARI for $80 per share in cash.